Literature DB >> 27411963

Interplay of genetic and epigenetic alterations in hepatocellular carcinoma.

Sun-Min Lee1, Jeongsil Kim-Ha2, Won-Young Choi3, Jungwoo Lee3, Dawon Kim3, Jinyoung Lee3, Eunji Choi3, Young-Joon Kim1,3.   

Abstract

Genetic and epigenetic alterations play prominent roles in hepatocarcinogenesis and their appearance varies depending on etiological factors, race and tumor progression. Intriguingly, distinct patterns of these genetic and epigenetic mutations are coupled not only to affect each other, but to trigger different types of tumorigenesis. The patterns and frequencies of somatic variations vary depending on the nature of the surrounding chromatin. On the other hand, epigenetic alterations often induce genomic instability prone to mutation. Therefore, genetic mutations and epigenetic alterations in hepatocellular carcinoma appear to be inseparable factors that accelerate tumorigenesis synergistically. We have summarized recent findings on genetic and epigenetic modifications, their influences on each other's alterations and putative roles in liver tumorigenesis.

Entities:  

Keywords:  DNA methylation; epigenetic modifications; genetic mutations; hepatocellular carcinoma; signaling pathways

Mesh:

Year:  2016        PMID: 27411963     DOI: 10.2217/epi-2016-0027

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  15 in total

1.  Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.

Authors:  Chih-Ching Yeh; Abhishek Goyal; Jing Shen; Hui-Chen Wu; Joshua A Strauss; Qiao Wang; Irina Gurvich; Rachael A Safyan; Gulam A Manji; Mary V Gamble; Abby B Siegel; Regina M Santella
Journal:  Ann Surg Oncol       Date:  2017-06-07       Impact factor: 5.344

2.  Subtype-specific CpG island shore methylation and mutation patterns in 30 breast cancer cell lines.

Authors:  Heejoon Chae; Sangseon Lee; Kenneth P Nephew; Sun Kim
Journal:  BMC Syst Biol       Date:  2016-12-23

3.  Age-related epigenetic regulation in the brain and its role in neuronal diseases.

Authors:  Jeongsil Kim-Ha; Young-Joon Kim
Journal:  BMB Rep       Date:  2016-12       Impact factor: 4.778

4.  Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross-sectional study (2016-2017).

Authors:  Christian S Alvarez; Jeremy Ortiz; Giovanna Bendfeldt-Avila; Yi Xie; Mingyi Wang; Dongjing Wu; Herbert Higson; Elisa Lee; Kedest Teshome; Joaquin Barnoya; David E Kleiner; John D Groopman; Roberto Orozco; Katherine A McGlynn; Eduardo Gharzouzi; Michael Dean
Journal:  Health Sci Rep       Date:  2020-05-06

Review 5.  Role of Gut Microbiota in Hepatocarcinogenesis.

Authors:  Haripriya Gupta; Gi Soo Youn; Min Jea Shin; Ki Tae Suk
Journal:  Microorganisms       Date:  2019-05-05

6.  DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.

Authors:  Yinan Zheng; Ryan A Hlady; Brian T Joyce; Keith D Robertson; Chunyan He; Drew R Nannini; Warren A Kibbe; Chad J Achenbach; Robert L Murphy; Lewis R Roberts; Lifang Hou
Journal:  Clin Epigenetics       Date:  2019-10-21       Impact factor: 6.551

7.  EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.

Authors:  Jia Wang; Yanlin Zhong; Guixia Meng
Journal:  Int J Clin Oncol       Date:  2021-07-21       Impact factor: 3.402

8.  Genetic Variants of lncRNA MALAT1 Exert Diverse Impacts on the Risk and Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma.

Authors:  Lan-Ting Yuan; Jer-Hwa Chang; Hsiang-Lin Lee; Yi-Chieh Yang; Shih-Chi Su; Chien-Liang Lin; Shun-Fa Yang; Ming-Hsien Chien
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

9.  LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.

Authors:  Sumadi Lukman Anwar; Britta Hasemeier; Elisa Schipper; Arndt Vogel; Hans Kreipe; Ulrich Lehmann
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

10.  Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.

Authors:  Songsong Wu; Sheng Chen; Ning Lin; Jianchuan Yang
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.